Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in the US

Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in the US

2005 Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings

Aballea, S. | Chancellor, J. | Raikou, M. | Drummond, M. | Weinstein, M. | Jourdan, S. | Carita, P. | Bridgewater, J. | Volume: 23, Issue: 16S (June 1 Supplement), Pages: 3532, c,